AI-Assisted Colonoscopy for Colorectal Cancer Detection
Trial Summary
What is the purpose of this trial?
Adenoma detection rate (ADR) is a validated quality metric for colonoscopy with higher ADR correlated with improved colorectal cancer outcomes. Artificial intelligence (AI) can automatically detect polyps on the video monitor which may allow endoscopists in training to improve their ADR. Objective and Purpose of the study: Measure the effect of AI in a prospective, randomized manner to determine its impact on ADR of Gastroenterology trainees.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the AI-Assisted Colonoscopy treatment for colorectal cancer detection?
Research suggests that AI-Assisted Colonoscopy can improve the detection of polyps, which are growths that can lead to colorectal cancer, by identifying areas that might be missed during a standard colonoscopy. However, some studies show mixed results, with AI not always increasing detection rates in real-world settings.12345
Is AI-assisted colonoscopy safe for humans?
AI-assisted colonoscopy has been studied in various trials, and while it improves the detection of polyps and adenomas (growths that can lead to cancer), there is no specific mention of safety concerns in the available research. This suggests that it is generally considered safe for use in humans.12367
How is AI-assisted colonoscopy different from other treatments for colorectal cancer detection?
AI-assisted colonoscopy uses artificial intelligence to help doctors find and identify polyps (small growths) during a colonoscopy, which can improve detection rates compared to traditional methods. This approach is unique because it leverages advanced technology to potentially reduce missed diagnoses, although its effectiveness in routine practice is still being evaluated.12356
Research Team
James Buxbaum, MD
Principal Investigator
University of Southern California
Eligibility Criteria
This trial is for Gastroenterology fellows at USC who perform endoscopies. They must agree to participate and give informed consent. Procedures in intensive care or operating rooms, or those done solely by faculty without the fellow as primary operator, are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Educational Session
Fellows undergo an educational session on quality metrics and AI software usage
Treatment
Fellows perform colonoscopies with and without AI to measure adenoma detection rate
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- AI use in Endoscopy Room
- Non-AI use Standard of Care endoscopy room
AI use in Endoscopy Room is already approved in European Union, United States, Japan, Canada for the following indications:
- Colorectal cancer screening
- Polyp detection
- Colorectal cancer screening
- Polyp detection
- Colorectal cancer screening
- Polyp detection
- Colorectal cancer screening
- Polyp detection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor